Spellman David A 4
4 · Akebia Therapeutics, Inc. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
Spellman David A
SVP, CFO and Treasurer
Transactions
- Sale
Common Stock
2023-02-27$0.81/sh−7,539$6,131→ 517,260 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.